Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Groupe Athena Inc. (OTC: GATA).

Full DD Report for GATA

You must become a subscriber to view this report.


Recent News from (OTC: GATA)

Groupe Athena reports Q1 results
Groupe Athena ( OTCPK:GATA ): Q1 GAAP EPS of $0.02. Revenue of $10.21M (-48.6% Y/Y) Press Release More news on: Groupe Athena Inc., Earnings news and commentary, Consumer stocks news, ,
Source: SeekingAlpha
Date: November, 26 2018 16:35
Groupe Athena, Inc. Posts 1st Quarter Results
Mumbai, India, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --  Groupe Athena, Inc. (Pink sheets GATA) announced today  revenues of $10,211,529 for the period ending September 30, 2018. Operating income before Depreciation and Amortization was $1,480,511 and reflects a Rese...
Source: GlobeNewswire
Date: November, 26 2018 16:30
Groupe Athena reports Q4 results
Groupe Athena ( OTCPK:GATA ): Q4 EPS of $0.02 More news on: Groupe Athena Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: July, 17 2018 08:39
Groupe Athena, Inc. Releases Year End Financials, Posts Strong Growth
Mumbai, India, July 17, 2018 (GLOBE NEWSWIRE) -- Groupe Athena, Inc. (Pink sheets GATA.PK) is very excited to post the results for their fiscal year ending June 30, 2018. Annual revenue for the period was $55,968,325. EBITDA for the year was also strong at $8,067,798 and net after tax incom...
Source: GlobeNewswire
Date: July, 17 2018 08:30
Groupe Athena reports Q2 results
Groupe Athena ( OTCPK:GATA ): Q2 EPS of $0.04 Revenue of $16.36M (+3.7% Y/Y) Press Release More news on: Groupe Athena Inc., Earnings news and commentary, Consumer stocks news, ,
Source: SeekingAlpha
Date: January, 17 2018 16:05
GROUPE ATHENA, INC. POSTS 2nd QUARTER RESULTS
Mumbai, India, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Groupe Athena, Inc. (OTC PINK:  GATA ) announced today  revenues of $16,364,908 for the period ending December 31, 2017, an increase of $578,619 over the same period in 2016. Operating income before Depreciation and Amortiza...
Source: GlobeNewswire
Date: January, 17 2018 16:00
Groupe Athena, Inc. Posts Strong 1st Quarter Results Approximating $20,000,000 in Revenues
MUMBAI, INDIA--(Marketwired - Nov 7, 2017) - Groupe Athena, Inc. ( OTC PINK : GATA ) today announced revenues of $19,864,908 for the fiscal quarter ending September 30, 2017, representing a 14% growth over the same period in 2016. Operating income before depreciation, amortization and taxes...
Source: Marketwired
Date: November, 07 2017 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-18N/A0.075N/AN/A0
2018-12-17N/A0.075N/AN/A0
2018-12-140.04150.0750.0750.04155,100
2018-12-13N/A0.047N/AN/A0
2018-12-12N/A0.047N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-049,10028,88031.5097Cover
2018-11-282,0004,00050.0000Short
2018-11-2722,40056,83039.4158Short
2018-11-162,9802,980100.0000Short
2018-10-303,1003,100100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GATA.


About Groupe Athena Inc. (OTC: GATA)

Logo for Groupe Athena Inc. (OTC: GATA)

Serving India and South East Asia, Groupe Athena has been serving companies abroad in obtaining FDA approval for pharmaceuticals, medical products and devices for export to the USA. Our goal is to ensure each of our clients passes FDA inspection by assisting them from concept through development, with consultation through all the regulatory requirements, filings, and processes to achieve FDA compliance and approval. lt br / gt lt br / gt With offices in India and America, the expert consultants of Groupe Athena are in position to go to American target companies and the regulatory authorities directly, consulting with our clients in the East to serve them completely in providing consultancy services for FDA compliance. Services include providing technical and regulatory consulting for biotechnical products, pharmaceuticals over the counter, prescription and generics , diagnostics, medical equipment, and devices. lt br / gt lt br / gt The FDA inspection process is traditionally complicated, especially for foreign drug and medical companies trying to export to the USA. With broad spectrum consultancy and assistance through this process, our client base can count on reduced risk, follow through on steps necessary for FDA compliance and identifying and solving breaches in compliance. lt br / gt lt br / gt From concept through final approval, Groupe Athena navigates companies through every requirement of the process including pharmaceutical consulting, development, and regulatory compliance to achieve FDA approval and export pharmaceuticals and medical products and equipment to the USA. lt br / gt lt br / gt lt br / gt Services Offered: lt br / gt lt br / gt Analytical QC lt br / gt QA Functions lt br / gt Readiness for Inspections lt br / gt Compliance lt br / gt Validation lt br / gt Clinical Trial Management lt br / gt Regulatory/Legal lt br / gt Preparation of Regulatory Filings IND s/PMA s/NDA s/ANDA s/ Ks etc lt br / gt Compliance Assessments GLP, GMP, GXP lt br / gt Risk Assessments lt br / gt Mock FDA Audits lt br / gt Medical Device Support lt br / gt CMC Support lt br / gt GMP Training lt br / gt Facility Layout Consulting lt br / gt Utilities, Process, IT, Computer, and Cleaning Validation lt br / gt Training

 

Contact Information

 

 

Current Management

  • Dipika Purohit / CEO

Current Share Structure

  • Market Cap: $3,770,952 - 03/12/2018
  • Authorized: 100,000,000 - 06/30/2016
  • Issue and Outstanding: 47,136,900 - 06/30/2016
  • Float: 7,815,450 - 06/30/2017

 


Recent Filings from (OTC: GATA)

Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: January, 17 2018
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: November, 07 2017

 

 


Daily Technical Chart for (OTC: GATA)

Daily Technical Chart for (OTC: GATA)


Stay tuned for daily updates and more on (OTC: GATA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: GATA)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GATA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GATA and does not buy, sell, or trade any shares of GATA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/